期刊文献+

超级伽玛刀治疗腹部晚期肿瘤的临床疗效

Application Value of Super Gamma Knife on Late Stage Abdominal Tumors
下载PDF
导出
摘要 [目的]探讨超级伽玛刀在腹部晚期肿瘤中的应用价值。[方法]对本院肿瘤外科收治的130例腹部晚期肿瘤患者采用伽玛刀进行治疗,3~6Gy/次,5次/周,总治疗次数6~15次,总治疗剂量36~55Gy的周期治疗,对不同类型肿瘤治疗的疗效及治疗后不良反应进行比较。[结果]治疗后患者卡氏功能状态(KPS)评分为(85.02土1.02)分,较治疗前(55.01±1.38)分显著增加,且治疗前后相比较差异具有显著性(P〈0.05);治疗后患者的肿瘤有较显著的缩小,且治疗后患者临床症状显著缓解,近期总有效率达到了93.07%(121/130);治疗后患者的整体疗效与其肿瘤体积(GTV)大小相关(P〈0.01);患者治疗副作用主要以胃肠道功能受到影响为主,主要不良反应有恶心、腹泻、腹痛、呕吐,均经对症治疗后有效缓解。[结论]超级伽玛刀治疗腹部晚期肿瘤患者临床疗效较好,且安全可靠,其在腹部晚期肿瘤治疗中具有较好的应用价值。 [Objective]To explore the application value of super gamma knife on late stage abdominal tumors. [Methods] One hundred and thirty cases of late stage abdominal tumor patients were selected as the research objects and underwent gamma knife treatmentof 3--6Gy/time, 5 times / week, with a total of 6 to 15 treatments and a total treatment dose of 36--55Gy. By means of suitable radiotherapy via super gamma knife in different types of late stage abdominal tumor patients, treatment efficacy and adverse reactions were ob- served and compared. [Results] The results showed that after treatment, the patient activity and function score evaluated byKPS (karnofsky performance status scale) was (85.02 ± 1.02) points compared to before treatment (55.01±1.38) points, which was a significant increase with statistical significance ( P〈0.05). After treatment, the tumors in patients showed significant shrink and clinical symptoms of the patients were significantly alleviated with treatment response efficiency 93.07 % (121/130). After treatment, the patients overall efficacy had a close relation with the global tumor volume (GTV, P〈0.01). Side effects after-treatment mainly affected gastrointestinal function; And the main adverse reactionslike nausea, diarrhea, abdominal pain, and vomiting, were effectively alleviated through symptomatic treatment.[Conclusion] The super gamma knife has a significant positive effect on patients with advanced abdominal tumor. It is safe and reliable, and has a wide range of clinical application value.
出处 《医学临床研究》 CAS 2016年第8期1570-1572,共3页 Journal of Clinical Research
关键词 Γ射线 放射外科手术 腹部肿瘤/放射疗法 Gamma Rays Radiosurgery Abdominal Neoplasms/RT
  • 相关文献

参考文献10

二级参考文献87

  • 1刘孟忠,王修身,蔡玲,古模发,刘慧,李群,崔念基,张亚奇,李国辉,李锦清.外照射配合肝动脉栓塞治疗不能手术切除的原发性肝癌的临床研究[J].癌症,2005,24(1):82-86. 被引量:8
  • 2夏廷毅.立体定向高分次剂量放疗早期非小细胞肺癌[J].中华放射肿瘤学杂志,2006,15(4):342-344. 被引量:18
  • 3夏廷毅,李宏奇,王颖杰,李平,孙庆选,范乃斌,于勇.全身γ刀治疗不能手术Ⅰ和Ⅱ期非小细胞肺癌的临床结果[J].中华放射肿瘤学杂志,2007,16(2):91-97. 被引量:56
  • 4Maemura K, Shinchi H, Noma H, et al. Comparison of hyper - fractionated accelerated and standard fractionated radiotherapy with concomitant low - dose gemcitabine for unresectable pancreatic cancer [ J ]. Anticancer Res,2008,28 (4C) :2369 - 2372. 被引量:1
  • 5Lo SS, Dawson LA, Kim EY, et al. Stereotactic body radiation therapy for hepatocellular carcinoma [ J ]. Discov Med, 2010, 9 (48) :404 -410. 被引量:1
  • 6Brown MW, Ning H, Arora B, et al. A dosimetric analysis of dose escalation using two intensity - modulated radiation therapy techniques in locally advanced pancreatic carcinoma [ J ]. Int J Radiat Oncol Biol Phys, 2006, 65:274 -283. 被引量:1
  • 7Bernhard J, Dietrich D, Scheithaner W, et al. Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemeitabine plus capecitabine versus gemcitabine alone : a random- ized multieenter phase III clinical trial - SAKK 44/00 - CECOG/ PAN. 1.3.001[J]. J Clin Oncol. 2008.26C22~ ..3695 -3701. 被引量:1
  • 8Baracs J, Husz~ O, Sajjadi SG, et al. Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS II ) : a randomized multicenter study, 2011,12:483-489. 被引量:1
  • 9Mackeen AD, Berghella V, Larsen ML. Techniques and materials for skin closure in caesarean section. Cochrane Database Syst Rev, 2012, 11 : CD003577. 被引量:1
  • 10纪宗正.围手术期处理//陈孝平.外科学.北京:人民卫生出版社,2002:188-191. 被引量:1

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部